Overview
- The chef told Times Radio that drugs like Wegovy, Ozempic and Mounjaro curb appetite, prompting diners to order smaller portions.
- Blumenthal has lost 8 kg on Wegovy, which he began using to counteract weight gain from his bipolar disorder medication.
- His Fat Duck Restaurant Group reported post-tax losses of £1.4 million in 2023 and £2.1 million in the year to May 2024.
- He predicts the squeeze on portion sizes will deepen over the next six months and sees supermarkets and airlines feeling downstream effects.
- Blumenthal cautioned that weight-loss injections may soon appear as over-the-counter patches or tablets, potentially accelerating appetite suppression.